Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Nov 27, 2019
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-11-25+4,997→ 1,282,634 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA) - Conversion
Exchangeable Shares
2019-11-25−4,997→ 17,476 total(indirect: Exchangeable Shares held through Lombard International Assurance SA)→ Common Stock (22,473 underlying)
Footnotes (1)
- [F1]The Exchangeable Shares of the Issuer's indirect subsidiary beneficially held by the Reporting Person are convertible into common stock of the Issuer at any time on a one-for-one basis for no consideration, and have no expiration date.